NEW YORK (GenomeWeb) – Opko Health today said that its proposed acquisition of Bio-Reference Laboratories has passed US antitrust review.

Early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 was granted yesterday, Opko said. The deal is still subject to other closing conditions including the approval of BRL's shareholders.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.